Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
1234567
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Liver Disease 2016 NIGMS 1P20GM113126-01 5963 Hepatic Stabilin-2 Mechanisms of Clearance HARRIS, EDWARD UNIVERSITY OF NEBRASKA LINCOLN NE $181,215
Liver Disease 2016 NIGMS 1P20GM113126-01 5964 Quantifying Biochemical Communication in Hepatocellular Carcinoma STAINS, CLIFF UNIVERSITY OF NEBRASKA LINCOLN NE $180,126
Liver Disease 2016 NIGMS 1P20GM113126-01 5965 In Vitro Liver Models to Investigate the Progression of Liver Fibrosis KIDAMBI, SRIVATSAN UNIVERSITY OF NEBRASKA LINCOLN NE $186,270
Liver Disease 2016 NIGMS 1P20GM109096-01A1 5995 Metabolism Core BORSHEIM, ELISABET ARKANSAS CHILDREN'S HOSPITAL RES INST AR $112,117
Liver Disease 2016 NIGMS 1P20GM113226-01 6168 Administrative Core MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $669,465
Liver Disease 2016 NIGMS 1P20GM113226-01 6169 OMICS CORE ZHANG, XIANG UNIVERSITY OF LOUISVILLE KY $346,275
Liver Disease 2016 NIGMS 1P20GM113226-01 6170 ANALYTICAL CORE BARVE, SHIRISH UNIVERSITY OF LOUISVILLE KY $230,850
Liver Disease 2016 NIGMS 1P20GM113226-01 6171 ANIMAL MODEL AND BIOREPOSITORY CORE ARTEEL, GAVIN UNIVERSITY OF LOUISVILLE KY $138,510
Liver Disease 2016 NIGMS 1P20GM113226-01 6172 Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease KIRPICH, IRINA UNIVERSITY OF LOUISVILLE KY $184,680
Liver Disease 2016 NIGMS 1P20GM113226-01 6173 Pathogenic role of PDE4 in hepatic stellate cell activation and TGF signaling GOBEJISHVILI, LEILA UNIVERSITY OF LOUISVILLE KY $184,680
Liver Disease 2016 NIGMS 1P20GM113226-01 6174 High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis DENG, ZHONG-BIN UNIVERSITY OF LOUISVILLE KY $184,680
Liver Disease 2016 NIGMS 1P20GM113226-01 6175 Mechanisms of Probiotics in Alcoholic Liver Disease FENG, WENKE UNIVERSITY OF LOUISVILLE KY $184,680
Liver Disease 2016 NIGMS 1P20GM113226-01 6176 Effects of Dietary Fat on the Hepatotoxicity of Environmental Arsenic WATSON, WALTER UNIVERSITY OF LOUISVILLE KY $184,680
Liver Disease 2016 NIDA 4R25DA013582-15 Clinical Addiction Research and Education Program SAMET, JEFFREY BOSTON MEDICAL CENTER MA $349,453
Liver Disease 2016 NIAAA 1K01AA024174-01 Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease PI, LIYA UNIVERSITY OF FLORIDA FL $145,057
Liver Disease 2016 NIEHS 4R01ES014638-11 Manganese Transport and Toxicity WESSLING-RESNICK, MARIANNE HARVARD SCHOOL OF PUBLIC HEALTH MA $452,229
Liver Disease 2016 NIEHS 4R01ES019964-05 Selective Ah Receptor Ligands Repress Acute-Phase Response PERDEW, GARY PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $393,289
Liver Disease 2016 NIDDK 5F32DK104592-02 The role of Foxl1 in the differentiation of hepatocytes and cholangiocytes TETA-BISSETT, MONICA UNIVERSITY OF PENNSYLVANIA PA $58,002
Liver Disease 2016 NIAID 4R01AI095097-05 HIV co-infection and HCV-induced liver fibrosis in vivo SU, LISHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $370,000
Liver Disease 2016 NHLBI 5R01HL119830-02 TTC39B in Metabolism TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Liver Disease 2016 NCI 5R01CA176001-03 Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis GROSSNIKLAUS, HANS EMORY UNIVERSITY GA $323,700
Liver Disease 2016 NIAID 5R01AI110577-02 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $450,062
Liver Disease 2016 NIDA 1DP2DA040244-01 Reaching the hardest of the hard-to-reach SOLOMON, SUNIL JOHNS HOPKINS UNIVERSITY MD $2,430,000
Liver Disease 2016 NIAID 5R01AI114748-02 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Liver Disease 2016 NIAID 5R03AI115171-03 Exploring HCV infection in engineered cultures of iPSC-derived human liver cells KHETANI, SALMAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $79,921
Liver Disease 2016 NIDDK 4R01DK093774-04 Hepatic Lipid Mobilization by Nuclear Hormone Receptors LEE, YOON-KWANG NORTHEAST OHIO MEDICAL UNIVERSITY OH $296,757
Liver Disease 2016 NIDDK 2P30DK089502-06 7318 Core D-Translational Research Enhancement POTTER, JAMES JOHNS HOPKINS UNIVERSITY MD $134,622
Liver Disease 2016 NIAAA 1R21AA023607-01A1 Mechanisms of Alcohol-Induced Hepatic Osteodystrophy CHUNG, CHUHAN YALE UNIVERSITY CT $240,781
Liver Disease 2016 NIAID 4R01AI103440-04 A molecular basis for control of T cell memory HEDRICK, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $465,000
Liver Disease 2016 NIDDK 2P30DK048522-21A1 7388 Administrative Core and Enrichment KAPLOWITZ, NEIL UNIVERSITY OF SOUTHERN CALIFORNIA CA $179,124
Liver Disease 2016 NIDDK 2P30DK048522-21A1 7389 Cell Separation and Culture Core STILES, BANGYAN UNIVERSITY OF SOUTHERN CALIFORNIA CA $196,406
Liver Disease 2016 NIDDK 2P30DK048522-21A1 7390 Analytical, Metabolic, Instrumentation Core OOKHTENS, MURAD UNIVERSITY OF SOUTHERN CALIFORNIA CA $190,166
Liver Disease 2016 NIDDK 2P30DK048522-21A1 7391 Cell and Tissue Imaging Core HAMM-ALVAREZ, SARAH UNIVERSITY OF SOUTHERN CALIFORNIA CA $125,390
Liver Disease 2016 NIDDK 2P30DK048522-21A1 7392 Liver Histology Core KANEL, GARY UNIVERSITY OF SOUTHERN CALIFORNIA CA $136,115
Liver Disease 2016 NIDDK 2P30DK048522-21A1 7393 Pilot and Feasibility Program DELEVE, LAURIE UNIVERSITY OF SOUTHERN CALIFORNIA CA $280,497
Liver Disease 2016 NCI 4R01CA051210-24 Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors ROSS, DAVID UNIVERSITY OF COLORADO DENVER CO $312,983
Liver Disease 2016 NCI 5R01CA120206-11 Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer MEHTA, ANAND DREXEL UNIVERSITY PA $329,172
Liver Disease 2016 NHLBI 5R01HL122822-02 Hepatic Wnt/LRP6 Regulation of Plasma Lipids MANI, ARYA YALE UNIVERSITY CT $521,751
Liver Disease 2016 NIAID 5R01AI104494-03 A screen for antiviral compounds targeting the Hepatitis B Virus ribonuclease H TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $337,500
Liver Disease 2016 NIAID 4R01AI104887-04 Control of Viral Pathogenesis by Regulation of 2-5A Levels WEISS, SUSAN UNIVERSITY OF PENNSYLVANIA PA $713,295
Liver Disease 2016 NIAID 5R21AI115120-02 PLASMABLASTS, XENOBIOTICS AND LOSS OF TOLERANCE LEUNG, PATRICK UNIVERSITY OF CALIFORNIA AT DAVIS CA $235,063
Liver Disease 2016 NIDA 4R01DA035146-04 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $608,005
Liver Disease 2016 NIDA 4P30DA011041-19 5121 Infectious Diseases and Biomedical Core PERLMAN, DAVID NEW YORK UNIVERSITY NY $102,568
Liver Disease 2016 NIDDK 5R00DK088962-05 Use of Discarded Organs for Preparation of Liver Grafts UYGUN, BASAK MASSACHUSETTS GENERAL HOSPITAL MA $249,000
Liver Disease 2016 NIAID 5UM1AI069418-10 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $2,052,913
Liver Disease 2016 NIAID 5UM1AI069503-10 Terry Beirn CPCRA Clinical Trials Unit GORDIN, FRED GEORGE WASHINGTON UNIVERSITY DC $5,055,518
Liver Disease 2016 NIAAA 4P60AA011605-19 5367 Pilot Projects CREWS, FULTON UNIV OF NORTH CAROLINA CHAPEL HILL NC $52,775
Liver Disease 2016 NCI 4R01CA030276-34 IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES NIEDERKORN, JERRY UT SOUTHWESTERN MEDICAL CENTER TX $282,171
Liver Disease 2016 NIAID 5UM1AI068632-10 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $11,550,503
Liver Disease 2016 NICHD 5UM1AI068632-10 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $4,478,297
Liver Disease 2016 NCI 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,100,000
Liver Disease 2016 NIAID 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $29,651,481
Liver Disease 2016 NIDA 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Liver Disease 2016 NINDS 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Liver Disease 2016 OD 5UM1AI068636-10 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $3,061,000
Liver Disease 2016 NCI 4F30CA176922-03 Recombinant Polymers for Transarterial Chemoembolization of Liver Cancer POURSAID, AZADEH UNIVERSITY OF UTAH UT $33,319
Liver Disease 2016 NIDDK 5R01DK101941-02 Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients GARG, ABHIMANYU UT SOUTHWESTERN MEDICAL CENTER TX $363,656
Liver Disease 2016 NIDDK 4R01DK078184-09 Factors controlling metabolic flux in the liver by NMR isotopomer analysis BURGESS, SHAWN UT SOUTHWESTERN MEDICAL CENTER TX $345,825
Liver Disease 2016 NIAID 5R37AI047365-17 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Liver Disease 2016 NCI 5R21CA185274-02 Magnetic Micelles for Catheter-Directed Sorafenib Delivery to Liver Tumors KIM, DONG-HYUN NORTHWESTERN UNIVERSITY AT CHICAGO IL $201,623
Liver Disease 2016 NHLBI 4R01HL112248-05 CEACAM1: A link between metabolic and cardiovascular diseases NAJJAR, SONIA UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $375,416
Liver Disease 2016 NIAAA 1P50AA024333-01 8230 Core A: Administrative Core NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $134,581
Liver Disease 2016 NIAAA 1P50AA024333-01 8232 Core C: Clinical Core MCCULLOUGH, ARTHUR CLEVELAND CLINIC LERNER COM-CWRU OH $168,149
Liver Disease 2016 NIAAA 1P50AA024333-01 8234 Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury BROWN, JONATHAN CLEVELAND CLINIC LERNER COM-CWRU OH $249,638
Liver Disease 2016 NIAAA 1P50AA024333-01 8235 Project 2: Lipin-1 and the development of ALD YOU, MIN CLEVELAND CLINIC LERNER COM-CWRU OH $253,395
Liver Disease 2016 NIAAA 1P50AA024333-01 8236 Project 3: Sarcopenia of ALD: Regulation of Skeletal Muscle Autophagy by Alcohol DASARATHY, SRINIVASAN CLEVELAND CLINIC LERNER COM-CWRU OH $244,899
Liver Disease 2016 NIAAA 1P50AA024333-01 8237 Project 4: Innate Immunity and Cell Death in ALD NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $249,638
Liver Disease 2016 NIAAA 1P50AA024337-01 8301 Omics Core ZHANG, XIANG UNIVERSITY OF LOUISVILLE KY $460,940
Liver Disease 2016 NIAAA 1P50AA024337-01 8302 Role of Dietary Fat in Alcoholic Liver Disease MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $68,216
Liver Disease 2016 NIAAA 1P50AA024337-01 8303 HDAC Mediated Epigenetic Mechanisms in Alcohol-Induced Abnormal Gut-Liver Axis BARVE, SHIRISH UNIVERSITY OF LOUISVILLE KY $157,040
Liver Disease 2016 NIAAA 1P50AA024337-01 8305 Mechanisms of Alcohol-Induced Lung and Liver Injury ROMAN, JESSE UNIVERSITY OF LOUISVILLE KY $172,671
Liver Disease 2016 NIAID 4UM1AI069536-10 HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) SPECTOR, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $2,074,220
Liver Disease 2016 NHLBI 5R42HL093879-04 A Percutaneous Ultrasound-Guided Catheter for Organ and Vascular Access DYKES, CHRISTOPHER PERCEPTIVE NAVIGATION, LLC MD $764,687
Liver Disease 2016 NHLBI 5K01HL121010-03 The Role of CD8+ T Cells In The Development of Nonalcoholic Fatty Liver Disease KENNEDY, ARION VANDERBILT UNIVERSITY TN $113,004
Liver Disease 2016 NCI 5R01CA175380-03 FoxM1 in liver cancer. RAYCHAUDHURI, PRADIP UNIVERSITY OF ILLINOIS AT CHICAGO IL $405,146
Liver Disease 2016 NIAID 4R01AI050611-12 A chicken model to study hepatitis E virus pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $393,587
Liver Disease 2016 NIDDK 5R01DK074932-10 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Liver Disease 2016 NCI 5R01CA181658-02 MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors LARSON, ANDREW NORTHWESTERN UNIVERSITY AT CHICAGO IL $441,814
Liver Disease 2016 NIAID 5U01AI115711-02 Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant GRINSPOON, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $685,269
Liver Disease 2016 NIAID 4K08AI102761-04 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $185,121
Liver Disease 2016 NIDDK 5K08DK099412-02 The role of macrophage migration inhibitory factor in autoimmune hepatitis ASSIS, DAVID YALE UNIVERSITY CT $152,874
Liver Disease 2016 NIDDK 5R01DK102182-02 Stem Cell-Based In vivo Models of Human Genetic Liver Diseases PELTZ, GARY STANFORD UNIVERSITY CA $548,072
Liver Disease 2016 NIDDK 5R01DK100603-02 Retinoic acid receptor, lipid metabolism, and fatty liver disease ZANG, MENGWEI BOSTON MEDICAL CENTER MA $391,500
Liver Disease 2016 NIDDK 5R01DK100319-04 IKKepsilon/TBK1 Inhibitors for the Treatment of Obesity and Type 2 Diabetes SALTIEL, ALAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $592,999
Liver Disease 2016 NIDDK 5R01DK100425-03 The Role of ChREBP in Fructose Induced Metabolic Disease HERMAN, MARK BETH ISRAEL DEACONESS MEDICAL CENTER MA $265,350
Liver Disease 2016 NIDDK 5F30DK105768-02 Roles for FoxO proteins in human liver development HANSEN, KAREN MEDICAL COLLEGE OF WISCONSIN WI $45,666
Liver Disease 2016 NIAID 5R01AI108765-03 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $435,000
Liver Disease 2016 NIAMS 4K23AR063770-04 A rational approach to liver toxicity monitoring in methotrexate users SCHMAJUK, GABRIELA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $137,160
Liver Disease 2016 OD 2R13AI071925-08 Liver Disease and HIV SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $40,000
Liver Disease 2016 NCI 4R01CA164574-04 Gender Disparity in Bladder Cancer and Chemopreventive Intervention ZHANG, YUESHENG ROSWELL PARK CANCER INSTITUTE CORP NY $330,992
Liver Disease 2016 NIDDK 5R01DK102597-02 NAFLD: Mechanisms and Treatments TIMCHENKO, NIKOLAI CINCINNATI CHILDRENS HOSP MED CTR OH $351,000
Liver Disease 2016 NIAAA 5P50AA011999-18 8452 Administrative Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $411,658
Liver Disease 2016 NIAAA 5P50AA011999-18 8464 Animal Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $472,310
Liver Disease 2016 NIAAA 5P50AA011999-18 8465 Mechanisms and Impact of StAR Activation in ALD FERNANDEZ-CHECA, JOSE UNIVERSITY OF SOUTHERN CALIFORNIA CA $156,829
Liver Disease 2016 NIAAA 5P50AA011999-18 8466 Origin and Fate of Myofibroblasts in Alcoholic Liver Disease BRENNER, DAVID UNIVERSITY OF SOUTHERN CALIFORNIA CA $135,636
Liver Disease 2016 NIAAA 5P50AA011999-18 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $203,571
Liver Disease 2016 NIAAA 5P50AA011999-18 8468 Alcohol Abuse and Pancreatic Necrosis PANDOL, STEPHEN UNIVERSITY OF SOUTHERN CALIFORNIA CA $132,088
Liver Disease 2016 NIAAA 5P50AA011999-18 8469 Pilot Project Program TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $107,900
Liver Disease 2016 NIAAA 4U01AA021838-04 Transcriptomics of Liver in Alcoholic Hepatitis NORDEN-KRICHMAR, TRINA UNIVERSITY OF CALIFORNIA-IRVINE CA $263,980
Liver Disease 2016 NIAAA 4U01AA021898-04 ALCOHOLIC HEPATITIS PATHOGENESIS AS DETERMINED FROM HUMAN LIVER TISSUE ANALYSIS FRENCH, SAMUEL LA BIOMED RES INST/ HARBOR UCLA MED CTR CA $210,123
Liver Disease 2016 NCI 4U01AI034994-23 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $106,140
Liver Disease 2016 NIAID 4U01AI034994-23 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $2,024,361
Liver Disease 2016 NICHD 4U01AI034994-23 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $214,936
Liver Disease 2016 NIDA 4U01AI034994-23 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $53,072
Liver Disease 2016 NIDCD 4U01AI034994-23 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $110,123
Liver Disease 2016 OD 4U01AI034994-23 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $18,901
Liver Disease 2016 NIAID 4R01AI070101-10 Mechanisms of hepatitis C virus persistence GRAKOUI, ARASH EMORY UNIVERSITY GA $440,000
Liver Disease 2016 NIDDK 5F32DK105845-02 Investigating Synthetic Ligands for the Treatment of NASH GRIFFETT, KRISTINE SAINT LOUIS UNIVERSITY MO $59,970
Liver Disease 2016 NIAID 4R01AI096882-05 Persistent hepatitis C virus replication and T cell immunity in pregnancy WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $584,545
Liver Disease 2016 NIAID 5R01AI116939-02 Carbapenem-resistant bacterial colonization and infection after liver transplant UHLEMANN, ANNE-CATRIN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Liver Disease 2016 NIDDK 5R01DK068437-11 Postprandial Vitamin A BLANER, WILLIAM COLUMBIA UNIVERSITY HEALTH SCIENCES NY $360,000
Liver Disease 2016 NIAID 5R01AI099506-03 Modulation of internal ribosome entry by ribosomal protein RPS25 SARNOW, PETER STANFORD UNIVERSITY CA $577,666
Liver Disease 2016 NIGMS 4R01GM103853-04 Cellular Signaling in Drug-induced Toxicity BUMPUS, NAMANDJE JOHNS HOPKINS UNIVERSITY MD $307,800
Liver Disease 2016 NICHD 5F31HD082965-02 Genetic and Pharmacological Regulation of Hepatic and lleal FXR During Pregnancy MOSCOVITZ, JAMIE RUTGERS, THE STATE UNIV OF N.J. NJ $24,784
Liver Disease 2016 NIAID 5U01AI115714-02 Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant STOCK, PETER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $604,473
Liver Disease 2016 NIDDK 5R01DK048252-22 Transgene Persistence in Liver Gene Therapy GROMPE, MARKUS OREGON HEALTH & SCIENCE UNIVERSITY OR $368,829
Liver Disease 2016 NIDDK 4R01DK078187-09 LIPIN 1 IN THE REGULATION OF HEPATIC LIPID METABOLISM FINCK, BRIAN WASHINGTON UNIVERSITY MO $330,600
Liver Disease 2016 NIDDK 4R01DK064008-13 Immunologic Dysfunction in Biliary Atresia BEZERRA, JORGE CINCINNATI CHILDRENS HOSP MED CTR OH $407,924
Liver Disease 2016 NIDDK 4R01DK084033-07 AAV Gene Therapy for AAT Deficiency SAMULSKI, RICHARD UNIV OF NORTH CAROLINA CHAPEL HILL NC $319,241
Liver Disease 2016 NIAID 5R01AI065429-12 Innate immunity to adenovirus SHAYAKHMETOV, DMITRY EMORY UNIVERSITY GA $592,500
Liver Disease 2016 NIAID 5R01AI116639-02 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Liver Disease 2016 NIDDK 4R01DK033765-33 Regulation of Sex Differences in Liver Metabolism WAXMAN, DAVID BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) MA $532,861
Liver Disease 2016 NIDDK 5R01DK099055-03 Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease PARK, IN-WOO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $334,839
Liver Disease 2016 NHLBI 4P01HL087123-09 7665 The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance TABAS, IRA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $543,352
Liver Disease 2016 NHLBI 4P01HL087123-09 7666 Hyperinsulinemia, mTOR Activity and Plasma Lipoproteins TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $538,135
Liver Disease 2016 NINDS 5R21NS091654-02 Development of Molecular Therapy for Carbamoyl Phosphate Synthetase Deficiency LIPSHUTZ, GERALD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $231,000
Liver Disease 2016 NIAAA 4K23AA019966-05 Circadian Desynchrony in Alcohol Induced Gut Leakiness SWANSON, GARTH RUSH UNIVERSITY MEDICAL CENTER IL $176,861
Liver Disease 2016 NIAAA 5R01AA023416-03 A Role of Hypothalamic Dysfunction in Alcoholic Liver Disease BUETTNER, CHRISTOPH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $476,719
Liver Disease 2016 NIDDK 5R13DK104611-02 Keystone Symposia Annual Meeting Series on Obesity WOODLAND, DAVID KEYSTONE SYMPOSIA CO $15,000
Liver Disease 2016 NIEHS 5R21ES023906-02 The antimicrobial triclosan is a potent liver tumor promoter YUEH, MEI-FEI UNIVERSITY OF CALIFORNIA SAN DIEGO CA $193,750
Liver Disease 2016 NIDDK 5R01DK062277-13 Role of Beta-Catenin Signaling in Liver Regeneration MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $384,294
Liver Disease 2016 NIDDK 5R01DK077704-08 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $337,125
Liver Disease 2016 NIDDK 5R01DK102791-02 Roles of Neogenin and Matriptase-2 in Hemojuvelin-Mediated Hepcidin Expression ZHANG, AN-SHENG OREGON HEALTH & SCIENCE UNIVERSITY OR $332,264
Liver Disease 2016 NIDDK 4K25DK098615-04 Role of SIRT3 in fetal programming and kidney dysfunction JONSCHER, KAREN UNIVERSITY OF COLORADO DENVER CO $130,915
Liver Disease 2016 NCI 5R01CA193244-06 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $368,367
Liver Disease 2016 NIDDK 4K23DK095707-04 An Assessment of Liver Disease in HIV-infected and HIV/HBV Co-infected Tanzanians HAWKINS, CLAUDIA NORTHWESTERN UNIVERSITY AT CHICAGO IL $126,889
Liver Disease 2016 NCI 2P30CA014089-41 8293 Gastrointestinal Cancers Research Program (Project-006) KAHN, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $35,512
Liver Disease 2016 NIAAA 5R01AA021390-03 KLF15 and circadian regulation of alcohol-induced liver injury LIN, ZHIYONG CASE WESTERN RESERVE UNIVERSITY OH $356,625
Liver Disease 2016 NIAAA 5R01AA021978-03 Role of ECM and inflammatory remodeling in alcohol-induced liver and lung damage ARTEEL, GAVIN UNIVERSITY OF LOUISVILLE KY $387,569
Liver Disease 2016 NIDDK 5R03DK105303-02 Hepatocyte Notch Signaling Regulates NASH PAJVANI, UTPAL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $80,000
Liver Disease 2016 NCI 4R01CA166111-04 Tumor antigen-specific T-cells and hepatocellular carcinoma KAPLAN, DAVID UNIVERSITY OF PENNSYLVANIA PA $332,000
Liver Disease 2016 NIAID 5R01AI113923-02 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $464,225
Liver Disease 2016 NIDA 5R34DA038530-02 A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $319,837
Liver Disease 2016 NIDDK 4R01DK059597-15 Genetic analysis of the ciliopathies ARPKD and Meckel syndrome HARRIS, PETER MAYO CLINIC ROCHESTER MN $308,075
Liver Disease 2016 NCI 5R01CA121275-08 Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC) LEONE, GUSTAVO OHIO STATE UNIVERSITY OH $316,102
Liver Disease 2016 NIAAA 5R21AA022702-02 Role of microRNAs in HSC-mediated fibrogenesis SCHRUM, LAURA CAROLINAS MEDICAL CENTER NC $207,000
Liver Disease 2016 NIAID 5K24AI118591-02 Patient-Oriented Research and Mentorship in HIV and Non-Communicable Diseases KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $152,146
Liver Disease 2016 NIAAA 5R01AA022986-02 CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease AVADHANI, NARAYAN UNIVERSITY OF PENNSYLVANIA PA $520,771
Liver Disease 2016 NCI 5R01CA190844-02 Hepatic Stellate Cells and Liver Cancer SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $358,306
Liver Disease 2016 NIDA 4K23DA031612-05 Supporting Health in Drug Treatment Court for Women with HIV or Hepatitis C MORSE, DIANE UNIVERSITY OF ROCHESTER NY $171,871
Liver Disease 2016 NIDDK 1R01DK107405-01 A PSGL-1 Glycopeptide Mimetic for Treatment of Metabolic Syndrome CHAIKOF, ELLIOT BETH ISRAEL DEACONESS MEDICAL CENTER MA $638,976
Liver Disease 2016 NIDDK 1R03DK107402-01 Organelle Dysfunction in Liver Inflammation MALHI, HARMEET MAYO CLINIC ROCHESTER MN $79,500
Liver Disease 2016 NIAID 4R01AI105035-04 CD4+ T Cells in Acute Versus Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $435,000
Liver Disease 2016 NCI 5R01CA086978-13 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Liver Disease 2016 NCI 5R01CA176012-03 Molecular and cellular communications in liver tumorigenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA SAN DIEGO CA $321,625
Liver Disease 2016 NIDDK 5P30DK097948-02 5070 RESEARCH BASE COMINELLI, FABIO CASE WESTERN RESERVE UNIVERSITY OH $390,368
Liver Disease 2016 NIDDK 5P30DK097948-02 5072 Biorepository Core FIOCCHI, CLAUDIO CASE WESTERN RESERVE UNIVERSITY OH $221,916
Liver Disease 2016 NIDDK 5P30DK097948-02 5073 Histology/Imaging Core PIZARRO, THERESA CASE WESTERN RESERVE UNIVERSITY OH $223,263
Liver Disease 2016 NIDDK 5P30DK097948-02 5742 Mouse Models Core COMINELLI, FABIO CASE WESTERN RESERVE UNIVERSITY OH $227,243
Liver Disease 2016 NIDDK 1R01DK107535-01 Regulation of Lipid Storage by mTORC1 BRIDGES, DAVID UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $342,000
Liver Disease 2016 NIDDK 1R01DK107498-01 Regulation of lipolysis by mTORC1 KANDROR, KONSTANTIN BOSTON UNIVERSITY MEDICAL CAMPUS MA $386,084
Liver Disease 2016 NIDDK 1R01DK107533-01 TIM-3 Negative Costimulation Signaling at the Innate-Adaptive Immune interface in Liver Transplant Ischemia-Reperfusion Injury KUPIEC-WEGLINSKI, JERZY UNIVERSITY OF CALIFORNIA LOS ANGELES CA $346,500
Liver Disease 2016 NINR 1R01NR016017-01 Symptom burden in End-Stage Liver Disease patient-caregiver dyads HANSEN, LISSI OREGON HEALTH & SCIENCE UNIVERSITY OR $385,000
Liver Disease 2016 NIAID 4U01AI104347-04 Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients FENG, SANDY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $941,479
Liver Disease 2016 NIDDK 5R01DK038389-28 Lipid transport in the intestine STORCH, JUDITH RUTGERS, THE STATE UNIV OF N.J. NJ $460,126
Liver Disease 2016 NIDDK 5F30DK104562-02 Lipid-mediated control of immune responses in hepatitis C virus infection NARAYANAN, SOWMYA UNIVERSITY OF VIRGINIA VA $48,576
Liver Disease 2016 NIAID 5R21AI107252-02 Anti-HBV therapeutics based on rare-cutting targeted endonucleases JEROME, KEITH FRED HUTCHINSON CANCER RESEARCH CENTER WA $228,715
Liver Disease 2016 NIAID 5R01AI111970-03 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,120,190
Liver Disease 2016 NIAID 5R01AI114630-02 Innate Immune Response to Hepatocyte Death CRISPE, IAN UNIVERSITY OF WASHINGTON WA $614,851
Liver Disease 2016 NIDDK 5R01DK104656-02 LncRNA as a New Mediator of Bile Acid Homeostasis WANG, LI UNIVERSITY OF CONNECTICUT STORRS CT $429,480
Liver Disease 2016 NIDDK 1R01DK107643-01 Mechanism of SREBP Cleavage Activating Protein Golgi-to-ER Recycling ESPENSHADE, PETER JOHNS HOPKINS UNIVERSITY MD $286,020
Liver Disease 2016 NCI 1R01CA202245-01 Biological roles and Mediator-dependent transcription mechanisms of RNA polymerase II(G) ROEDER, ROBERT ROCKEFELLER UNIVERSITY NY $387,731
Liver Disease 2016 NHLBI 1R01HL130864-01 Liver-Mediated Clearance of Low Molecular Weight Heparins HARRIS, EDWARD UNIVERSITY OF NEBRASKA LINCOLN NE $374,800
Liver Disease 2016 NIDDK 1R01DK107904-01 Human population based genetic studies to elucidate the biology of NAFLD SPELIOTES, ELIZABETH UNIVERSITY OF MICHIGAN MI $775,142
Liver Disease 2016 NIMHD 1R01MD010358-01 Nutrigenetic Intervention to Reduce Liver Fat in Hispanics GORAN, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $780,908
Liver Disease 2016 NIGMS 5R01GM066411-11 Targeting Dynamics of CAR and PXR in the Mouse and Human Genomes OMIECINSKI, CURTIS PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $373,750
Liver Disease 2016 NIAID 4R01AI097318-06 Underlying Mechanisms of ApoE in HCV Infection and Assembly LUO, GUANGXIANG UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $367,500
Liver Disease 2016 NIAID 5R44AI106215-03 Development of a Microfluidic Point-of-Care HCV Viral Load Assay FERNANDEZ-SUAREZ, MARTA DAKTARI DIAGNOSTICS, INC. MA $597,342
Liver Disease 2016 NIAID 5R21AI118337-02 Host and viral determinants of hepatitis C virus macaque infection EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $263,629
Liver Disease 2016 NIDA 4R01DA015612-14 Making Better Decisions: Policy Modeling for AIDS and Drug Abuse OWENS, DOUGLAS STANFORD UNIVERSITY CA $623,455
Liver Disease 2016 NIDDK 5F32DK102284-03 Catalytic Independent Functions of Histone Deacetylase 3 in Metabolism ARMOUR, SEAN UNIVERSITY OF PENNSYLVANIA PA $39,860
Liver Disease 2016 NIDDK 5R01DK102965-02 The role of TCTP in regulating adiponectin signaling DONG, LILY UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $340,290
Liver Disease 2016 NIGMS 9R01GM118122-16 Metabolism of Carcinogens and Drugs by Human P450s GUENGERICH, F VANDERBILT UNIVERSITY TN $368,951
Liver Disease 2016 NIAID 1K08AI121348-01 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $184,637
Liver Disease 2016 NIDDK 5R01DK083567-07 ROCK1 signaling in glucose metabolism KIM, YOUNG-BUM BETH ISRAEL DEACONESS MEDICAL CENTER MA $391,500
Liver Disease 2016 NIDDK 5R01DK098424-03 Chemical probes targeting nuclear effector complex of the Hippo signaling pathway PAN, DUOJIA JOHNS HOPKINS UNIVERSITY MD $27,526
Liver Disease 2016 NIAAA 5K23AA023753-02 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $186,192
Liver Disease 2016 NCI 5R01CA190776-02 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $636,299
Liver Disease 2016 NIDA 5R01DA027379-05 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $485,416
Liver Disease 2016 NIDDK 5R01DK054468-13 Mitochondrial Metabolism in Primary Hyperoxaluria HOLMES, ROSS UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $379,242
Liver Disease 2016 NIAAA 5R21AA022720-02 BMAL1: A Novel Regulator For Inflammatory Liver Injury YIN, LEI UNIVERSITY OF MICHIGAN MI $222,813
Liver Disease 2016 NIAAA 4R01AA021276-05 MicroRNA regulation of CTGF in hepatic stellate cells BRIGSTOCK, DAVID RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $325,800
Liver Disease 2016 NIAAA 5R00AA020514-06 Regulation of hepatic stellate cells in development and alcoholic liver injury YIN, CHUNYUE CINCINNATI CHILDRENS HOSP MED CTR OH $237,095
Liver Disease 2016 NIDDK 5R03DK102480-02 Burden of Hospitalization After Liver Transplantation SHARMA, PRATIMA UNIVERSITY OF MICHIGAN MI $77,500
Liver Disease 2016 NCI 1R21CA190945-01A1 Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma KASEB, AHMED UNIVERSITY OF TX MD ANDERSON CAN CTR TX $174,000
Liver Disease 2016 NIAAA 1R21AA024543-01 Alcohol-Induced Mitochondrial Dysfunction and the Hepatocyte Clock BAILEY, SHANNON UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $211,313
Liver Disease 2016 NIDDK 4R01DK097164-04 Circadian molecular regulation of the xenobiotic response LAMIA, KATJA SCRIPPS RESEARCH INSTITUTE CA $418,688
Liver Disease 2016 NIDDK 4R01DK062777-13 Regulation of cholesterol catabolism by bile acids KEMPER, JONGSOOK UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $344,955
Liver Disease 2016 NIDDK 4R01DK072166-09 Regulation and function of the transferrin receptor 2 ENNS, CAROLINE OREGON HEALTH & SCIENCE UNIVERSITY OR $393,265
Liver Disease 2016 NIDDK 5K08DK101754-03 New Hepatocyte Model Systems to study Hepatitis B Virus Infection SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $153,457
Liver Disease 2016 NIDDK 5R01DK103185-02 Homeostatic role of IRE1a-XBP1-PDI1 in hepatic lipid metabolism KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $585,000
Liver Disease 2016 NIEHS 1R03ES026397-01 Development of integrative models for early liver toxicity assessment WANG, TAO UT SOUTHWESTERN MEDICAL CENTER TX $81,000
Liver Disease 2016 NIDDK 1R03DK107912-01 Vinyl chloride-NAFLD interaction BEIER, JULIANE UNIVERSITY OF LOUISVILLE KY $76,750
Liver Disease 2016 NIDDK 5F32DK104461-02 Regulation of glucose homeostasis by intestinal macronutrients and surgery SCARLETT, JARRAD UNIVERSITY OF WASHINGTON WA $64,146
Liver Disease 2016 NIAID 5R01AI106005-03 Dissecting virus neutralizing determinants to guide HCV vaccine development LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $450,000
Liver Disease 2016 NCI 5R01CA168912-03 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI GEORGIA REGENTS UNIVERSITY GA $320,588
Liver Disease 2016 NIDDK 5R37DK083834-32 Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway MONTMINY, MARC SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $730,528
Liver Disease 2016 NIDDK 4R01DK091592-05 Regulation of hepatic lipid metabolism by a novel Foxo pathway DONG, X INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $339,300
Liver Disease 2016 NIAID 1R21AI122155-01 PACAP Mediated Neural Regulation of Hepatic Inflammation in Orthotopic Liver Transplantation JI, HAOFENG UNIVERSITY OF CALIFORNIA LOS ANGELES CA $192,500
Liver Disease 2016 NIAID 1R21AI122228-01 The impact of quasi-envelopment on hepatitis virus infection and immunity FENG, ZONGDI RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $186,875
Liver Disease 2016 NIDDK 2R01DK056621-15A1 Hepatic autophagy, Stem cells and Fibrosis FRIEDMAN, SCOTT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $381,375
Liver Disease 2016 NCI 1R01CA190209-01A1 Targeting the Premetastatic Niche by Antiangiogenic Immunotherapy MARKIEWSKI, MACIEJ TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $349,988
Liver Disease 2016 NCI 4U01CA172320-04 Evaluation of HCC Response to Systemic Therapy with Quantitative MRI TAOULI, BACHIR ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $514,057
Liver Disease 2016 NIAMS 5R01AR056672-07 The Pharmacology of Dermal Fibrosis CRONSTEIN, BRUCE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $372,900
Liver Disease 2016 NICHD 5R01HD075549-03 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $318,609
Liver Disease 2016 NIA 5R01AG016927-18 The Role of Akt in Cell Survival and Cell Growth HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $451,912
Liver Disease 2016 NCI 5R01CA185169-03 Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics MCKNIGHT, STEVEN UT SOUTHWESTERN MEDICAL CENTER TX $475,351
Liver Disease 2016 NIDDK 5F31DK105595-02 Regulation of de novo lipogenesis through BAD-dependent glucose signaling LANE, ELIZABETH HARVARD MEDICAL SCHOOL MA $31,045
Liver Disease 2016 NCI 4R01CA157880-05 Paracrine Role of Endothelial Cells on the Colorectal Cancer Stem Cell Phenotype ELLIS, LEE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $296,558
Liver Disease 2016 NCI 4R01CA166213-05 Super-infection and virus spread during chronic hepadnaviral infection GUDIMA, SEVERIN UNIVERSITY OF KANSAS MEDICAL CENTER KS $319,945
Liver Disease 2016 NCI 5R01CA183071-03 Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition VIGNERON, DANIEL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $655,718
Liver Disease 2016 NIDDK 5R01DK028082-34 Metabolic Actions of FGF21 MARATOS-FLIER, ELEFTHERIA BETH ISRAEL DEACONESS MEDICAL CENTER MA $658,162
Liver Disease 2016 NIDDK 5R01DK100301-03 The Fetal Hepatocyte Phenotype and Cell-Based Therapy for Liver Disease GRUPPUSO, PHILIP RHODE ISLAND HOSPITAL RI $347,384
Liver Disease 2016 NIDDK 5R01DK102559-03 Novel transcriptional regulators of bile acid metabolism and hepatotoxicity EDWARDS, PETER UNIVERSITY OF CALIFORNIA LOS ANGELES CA $334,950
Liver Disease 2016 NIEHS 4R01ES021375-05 PCBs worsen obesity/metabolic syndrome through 'toxic metabolic endotoxemia' CAVE, MATTHEW UNIVERSITY OF LOUISVILLE KY $337,500
Liver Disease 2016 NIGMS 5R01GM108618-03 Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure CARCILLO, JOSEPH UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $522,850
Liver Disease 2016 NHLBI 5R00HL111206-05 Role of FoxO1 in Lipid Metabolism HAEUSLER, REBECCA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $249,000
Liver Disease 2016 NCI 1R21CA201963-01 Metabolic Reprogramming of Colon Cancer Liver Metastasis SHEN, XILING DUKE UNIVERSITY NC $207,495
Liver Disease 2016 NCI 1R03CA201988-01 Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma TSAI, ROBERT TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $74,250
Liver Disease 2016 NIDA 4R01DA012568-18 INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,250,722
Liver Disease 2016 NIDDK 4K23DK090209-05 Gender and hormonal influences on liver fibrosis after transplant for hepatitis C FORDE, KIMBERLY UNIVERSITY OF PENNSYLVANIA PA $182,110
Liver Disease 2016 NIDDK 4K01DK096042-04 Enhancement of NAFLD risk by vinyl chloride: interaction of gut-liver-adipose axi BEIER, JULIANE UNIVERSITY OF LOUISVILLE KY $120,690
Liver Disease 2016 NIDDK 5K01DK104993-02 Role of LncRNAs in diabetic livers LEUNG, AMY BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $153,576
Liver Disease 2016 NIGMS 4R01GM059419-14 Mitochondrial Calcium Signaling in Cell Death HAJNOCZKY, GYORGY THOMAS JEFFERSON UNIVERSITY PA $315,755
Liver Disease 2016 NIAID 5U19AI109965-03 5820 Novel Nucleic Acid Sensing NLRs and Innate Immunity to Viruses TING, JENNY UNIV OF NORTH CAROLINA CHAPEL HILL NC $416,818
Liver Disease 2016 NIAID 5U19AI109965-03 5821 Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $407,731
Liver Disease 2016 NIAID 5U19AI109965-03 5825 Protein Purification and Biochemistry DUNCAN, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $328,213
Liver Disease 2016 NIDDK 4P30DK056338-14 5066 FUNCTIONAL GENOMICS AND MICROBIOME CORE VERSALOVIC, JAMES BAYLOR COLLEGE OF MEDICINE TX $195,625
Liver Disease 2016 NIDDK 5R44DK083843-06 Serum Hepcidin Immunoassay: Laboratory to Marketplace WESTERMAN, MARK INTRINSIC LIFESCIENCES, LLC CA $1,368,932
Liver Disease 2016 NIGMS 4P41GM103314-43 National Resource for Mass Spectrom of Biological Macromolecules CHAIT, BRIAN ROCKEFELLER UNIVERSITY NY $1,619,191
Liver Disease 2016 NIGMS 5R01GM112044-02 Data-Driven Models of the Dynamic Proteome in NAFLD SADYGOV, ROVSHAN UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $312,660
Liver Disease 2016 NICHD 5R01HD041230-12 Prenatal Metabolic Programming of the Offspring DEVASKAR, SHERIN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $316,354
Liver Disease 2016 NHLBI 5R01HL077588-13 Regulation of Cellular Cholesterol Homeostasis ESPENSHADE, PETER JOHNS HOPKINS UNIVERSITY MD $398,434
Liver Disease 2016 NIDDK 1R01DK104893-01A1 Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis ZHOU, HUIPING VIRGINIA COMMONWEALTH UNIVERSITY VA $411,742
Liver Disease 2016 NHLBI 1R01HL127174-01A1 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $504,478
Liver Disease 2016 NCI 1R03CA182132-01A1 Inositol-trisphosphate 3-kinase and colorectal cancer cell adhesion GASPERS, LAWRENCE RBHS-NEW JERSEY MEDICAL SCHOOL NJ $79,500
Liver Disease 2016 NIDA 5R01DA016065-13 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $700,614
Liver Disease 2016 NIDDK 5R01DK104998-02 Regulation of Hepatic Gluconeogenesis by the Mitochondrial Pyruvate Carrier TAYLOR, ERIC UNIVERSITY OF IOWA IA $370,868
Liver Disease 2016 NIDDK 5R01DK105847-02 Bile Diversion: A Simple and Effective Method of Treating Obesity ABUMRAD, NAJI VANDERBILT UNIVERSITY TN $73,803
Liver Disease 2016 NIDDK 1R01DK105033-01A1 Novel mechanisms of UPR sensing and nonalcoholic fatty liver disease LI, ZIHAI MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $336,375
1234567


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer